🎢 Your Options Alert for Aug 14 (Thursday)

Open Email...Your Power Lunch Trades Ideads Inside…
Your Notable Earnings Report

Unsubscribe

This $7 robot stock could surge by August 🚀 (Backed by Nvidia, Amazon, Sequoia and more)— Don't miss out ⌛(ad)
Dear Reader,
I hope you are having a great Thursday! I am sending you the list of options signals for the next trading day (to help you cut your research in finding trading and/or investing opportunities).

😮 The "Don't Eat Me" Cancer Breakthrough 📈 (ad)**
A next-gen therapy aims to unmask cancer cells so the immune system can destroy them — without the safety risks that sank earlier attempts. A $500M capital twist could fuel the race.
👉 Click to see why this is on watch.

Stock NameSignal DateSignal Name
TSLAAug 14 Golden Crossover
BRK-AAug 14 Golden Crossover
BRK-BAug 14 Golden Crossover
N0WAug 14 Golden Crossover
TMOAug 14 Below 200-MA
EPDAug 14 Below 200-MA
DLRAug 14 Below 200-MA
PCARAug 14 Below 200-MA
ADIAug 14 Double Top
AMTAug 14 Double Top
GRMNAug 14 Double Top
AIGAug 14 Double Top
LOWAug 14 Double Bottom
CMCSAAug 14 Double Bottom
STZAug 14 Double Bottom
STLAAug 14 Double Bottom
Click Here to View Your Full Report

Low-Float Biotech With Dual Billion-Dollar Targets 💰 (ad)**
A breakthrough cancer treatment and a military-backed artificial blood program. Plus a bold $500M funding plan that could make this one of the market's fastest movers on headlines.
🤩 Get the full story now.

How to use signals in your trading/investing strategies:
Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's trade signal) or the Price Reversal strategy (to target the reversal following signal generation). Please click on Ride-the-Wave Strategy to learn more about it.
Stock Trading - If you're a swing stock trader/investor or portfolio manager, you may want to consider entering or exiting your positiosn based on a the signal generation. Please click on Volatility Crush Strategy to learn more about it.

Palantir's Stock Is Climbing and So Is Their New Partner's (ad)*
It's a model built to scale. And it's live right now. This is not a crowded trade. It's still under the radar. But not for long. The AI arms race is heating up. And this partnership could signal a breakout moment.
See what Palantir saw. Learn more and unlock the symbol here by subscribing. (Click to Opt-in)

At Options Hero, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader.
To your trading success,
Support Team
Options Hero
PS:Options Hero is morning newsletter, powered by StockEarnings proprietary technology.
📈 Beat Volatility with These 3 Dividend Powerhouses
After the early‑April market downturn sparked by new trade measures, income picks are in hot demand. Our free report teases 3 High-Yield Dividend Stocks that could anchor your returns:
📥 [Download Your Free Guide Now] .

(ad)* This message is a PAID ADVERTISEMENT for Knightscope, Inc (NASDAQ:KSCP) from Market Jar Media Inc. StockEarnings, Inc. has received a fixed fee of $10,000 from Market Jar Media Inc for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between August 1, 2025 and August 31, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Knightscope, Inc (NASDAQ:KSCP) or Market Jar Media Inc. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Knightscope, Inc (NASDAQ:KSCP) on TradingWhisperer website for additional information about the relationship between Market Jar Media Inc and Knightscope, Inc (NASDAQ:KSCP).

(ad)** This message is a PAID ADVERTISEMENT for Liminatus Pharma Inc (NASDAQ:LIMN) from Market Jar Media Inc. StockEarnings, Inc. has received a fixed fee of $25000 from Market Jar Media Inc for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between August 14, 2025 and August 21, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Liminatus Pharma Inc (NASDAQ:LIMN) or Market Jar Media Inc. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Liminatus Pharma Inc (NASDAQ:LIMN) on TradingWhisperer website for additional information about the relationship between Market Jar Media Inc and Liminatus Pharma Inc (NASDAQ:LIMN).

Options Hero is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities.

This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised.

All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers.

StockEarnings Inc

33 SE 4th St, Suite 100,

Boca Raton, FL 33432 USA | W: 877.6.STOCKS

Unsubscribe


Today's Bonus Content: Palantir's Stock Is Climbing and So Is Their New Partner's (ad)*

Post a Comment

Previous Post Next Post

Contact Form